Cargando…
Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487609/ https://www.ncbi.nlm.nih.gov/pubmed/37685959 http://dx.doi.org/10.3390/ijms241713151 |
_version_ | 1785103283827769344 |
---|---|
author | Okodo, Mitsuaki Okayama, Kaori Sasagawa, Toshiyuki Teruya, Koji Settsu, Rei Mizuno, Shuichi Ishii, Yasuyoshi Oda, Mizue |
author_facet | Okodo, Mitsuaki Okayama, Kaori Sasagawa, Toshiyuki Teruya, Koji Settsu, Rei Mizuno, Shuichi Ishii, Yasuyoshi Oda, Mizue |
author_sort | Okodo, Mitsuaki |
collection | PubMed |
description | The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the cervix, whereas the preferential infection site for low-risk (LR) types is not well defined. The determination of HPV tropism when using cytology samples can be uncertain since it is difficult to avoid contamination of cell samples between the cervix and the vagina. Herein, cell samples were carefully collected by independently scraping the cervix and vagina, after which the HPV types were determined. HPV tissue tropism was determined by considering what HPV types were positive at only one of the sites (the cervix or the vagina) as the viruses that preferentially infected that site. This method revealed that all LR types were only identified in vaginal samples, whereas 87% of HR types were identified in cervical sites. Thus, LR types may preferentially infect the vagina, whereas HR types infect the cervix. These findings suggest that preferential tissue tropism of certain HPV types is a probable factor for malignant progression. |
format | Online Article Text |
id | pubmed-10487609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104876092023-09-09 Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses Okodo, Mitsuaki Okayama, Kaori Sasagawa, Toshiyuki Teruya, Koji Settsu, Rei Mizuno, Shuichi Ishii, Yasuyoshi Oda, Mizue Int J Mol Sci Article The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the cervix, whereas the preferential infection site for low-risk (LR) types is not well defined. The determination of HPV tropism when using cytology samples can be uncertain since it is difficult to avoid contamination of cell samples between the cervix and the vagina. Herein, cell samples were carefully collected by independently scraping the cervix and vagina, after which the HPV types were determined. HPV tissue tropism was determined by considering what HPV types were positive at only one of the sites (the cervix or the vagina) as the viruses that preferentially infected that site. This method revealed that all LR types were only identified in vaginal samples, whereas 87% of HR types were identified in cervical sites. Thus, LR types may preferentially infect the vagina, whereas HR types infect the cervix. These findings suggest that preferential tissue tropism of certain HPV types is a probable factor for malignant progression. MDPI 2023-08-24 /pmc/articles/PMC10487609/ /pubmed/37685959 http://dx.doi.org/10.3390/ijms241713151 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Okodo, Mitsuaki Okayama, Kaori Sasagawa, Toshiyuki Teruya, Koji Settsu, Rei Mizuno, Shuichi Ishii, Yasuyoshi Oda, Mizue Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title | Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title_full | Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title_fullStr | Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title_full_unstemmed | Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title_short | Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses |
title_sort | preferential tissue sites of different cancer-risk groups of human papillomaviruses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487609/ https://www.ncbi.nlm.nih.gov/pubmed/37685959 http://dx.doi.org/10.3390/ijms241713151 |
work_keys_str_mv | AT okodomitsuaki preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT okayamakaori preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT sasagawatoshiyuki preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT teruyakoji preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT settsurei preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT mizunoshuichi preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT ishiiyasuyoshi preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses AT odamizue preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses |